Pathogenesis and treatment of Epstein-Barr virus infection.
Pagano
J S
JS
Lineberger Cancer Research Center, School of Medicine, University of North Carolina, Chapel Hill 27514.
D000208:Acute Disease; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002051:Burkitt Lymphoma / Q000209:etiology; D002908:Chronic Disease; D004854:Herpesvirus 4, Human; D006801:Humans; D007244:Infectious Mononucleosis / Q000188:drug therapy / Q000209:etiology*; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy / Q000209:etiology; D012008:Recurrence; D014412:Tumor Virus Infections / Q000188:drug therapy / Q000209:etiology*
D000998:Antiviral Agents; D000212:Acyclovir